Prescribing. -Clinical Commissioning Groups - CCG. -Prescribing teams. -epact data. -APC & Joint Formulary. -Traffic lights and shared care protocols

Size: px
Start display at page:

Download "Prescribing. -Clinical Commissioning Groups - CCG. -Prescribing teams. -epact data. -APC & Joint Formulary. -Traffic lights and shared care protocols"

Transcription

1 Prescribing -Clinical Commissioning Groups - CCG -Prescribing teams -epact data -APC & Joint Formulary -Traffic lights and shared care protocols -Medication review -Unlicensed meds / Specials

2 Primary Care Prescribing Team. Part of the prescribing and medicine management team Prescribing advisors - Alison Hale for Mansfield & Ashfield CCG Primary Care Pharmacist & Prescribing Support Technician allocated to each practice

3 What do we do? Monitor prescribing and budgets Annual prescribing visit Help practices work on their prescribing areas Cost effective, evidence based prescribing NICE and APC implementation Clinics & Audits Training Medicine queries & MHRA alerts

4 How is prescribing monitored? All NHS prescriptions sent for payment to the Prescription Pricing Division (PPD). Recorded against prescriber number Analysis available after approx. 2-3mths Forms epact data and reports

5 NSAID prescribing across the CCG

6 Range of NSAIDs in one practice

7 Prescribing of diclofenac drilled down to prescriber within one practice Prescriber Name BNF Name Total Items Dr 1 Diclofenac Sod_Tab E/C 50mg 11 Dr 2 Diclofenac Sod_Tab E/C 50mg 1 Dr 3 Diclofenac Sod_Tab E/C 50mg 1 Dr 4 Diclofenac Sod_Tab E/C 50mg 1 Nurse 1 Diclofenac Sod_Tab E/C 50mg 1

8 Prescribing responsibility It is the prescriber who signs the prescription who carries legal responsibility, not the person who may suggest it!

9 Prescribing guides Mrs LE has seen Dr Millard a dermatology consultant at QMC about her discoid lupus erythematosus. He would like you to prescribe Chloroquine to treat the condition dose = chloroquine (as base) 150mg daily. - You check the dose in the BNF and the indication and dose are correct do you prescribe??

10 Checking a new medicine Is the indication and the dose reasonable? Is the dose licensed? Has it been given a traffic light? Does any monitoring need to be arranged As a prescriber do I have enough knowledge to prescribe?

11 APC & Traffic lights - 1 Area Prescribing Committee APC website Drugs are considered for classification at APC Shared care guidelines / clinical guidelines Formularies / position statements

12 APC & Traffic lights - 2 Joint formulary website Is it on M&A Preferred Prescribing List (PPL)? The website is a guide and GPs can choose not to follow it if they believe they have reason, but the reason should be documented.

13 What do the traffic lights mean? Red specialist secondary care only Amber 1 initiated by specialist, shared care once stable (with a protocol) Amber 2 primary care prescribing after specialist recommendation Amber 3 Primary care / non specialist may initiate under APC guideline Green routine use Grey not recommended at the present as limited clinical/cost effective data

14 Prescribing guides Mrs LE has seen Dr Millard a dermatology consultant at QMC about her discoid lupus erythematosus. He would like you to prescribe Chloroquine to treat the condition dose = chloroquine (as base) 150mg daily. - You check the dose in the BNF and the indication and dose are correct do you prescribe??

15 JF traffic lights suggests

16 What about MRS LE? The dose prescribed would be reasonable The traffic light list states chloroquine is red for dermatology in this condition. Refer back to consultant and ask that they retain prescribing responsibility

17 Scenario 2 MR HT has had a heart transplant at Newcastle Hospital in 2001 and is stable on his anti-rejection medication including tacrolimus and azathioprine. He has recently moved to the area from Durham and wants you to prescribe these as his last GP did. He only has one week supply left Do you prescribe?

18 Mr HT Both medications are traffic lighted as RED in Nottinghamshire No local heart transplant specialist Contact the specialist at Tertiary centre Request consultant takes back the prescribing Confirm the dosages needed and supply enough until the prescribing can be passed back Consultant will prescribe and CCG will be charged for the cost of this medicine.

19 Mrs T (Part one) Has RA Started oral methotrexate by hospital now on 20mg weekly Consultant writes to ask you to prescribe Do you agree to prescribe?

20 Shared care protocol Shared clinical responsibility outlined in a standard agreement Passed by APC Only for stable patients For the stated clinical diagnosis only

21 Prescribing methotrexate Always 2.5mg tablets Take.. tablets ONCE A WEEK on a SATURDAY

22 Mrs T (Part 2) Mrs T visits the consultant on a routine appointment Consultant now asking you to prescribe methotrexate 10mg twice weekly as nausea with once weekly dosage Do you prescribe?

23 Practice prescribing meeting. Yearly meeting 3 action points & audit as part of Prescribing Incentive Scheme Large report covering therapeutic areas Evidence of completion needed to obtain the money.

24

25

26 Controlled drugs

27

28 CD requirements Appropriate dosage? to be taken as directed not sufficient One to be taken as directed 15mg to be taken when required How long is it valid for? 28 days Treatment length Good practice for a maximum of 30 days. Need good reason documenting for any longer

29 If anyone collects a CD for a patient from the pharmacy they will need to: Sign the back of the prescription State their relationship with the patient Provide proof of identification Give their address for the pharmacy CD register

30 Can CD s be destroyed? A GP practice can take back a patients unused CD s and destroy them NO A GP can destroy any out of date CD s in the doctors bag with the witness of another GP NO

31 Other CD info All private prescriptions for schedule 2 and 3 CD s need to be on a FP10PCD All CD s in a surgery or doctors bag need to be recorded in a CD register and monitored

32 Specials - Unlicensed / off label Unlicensed medication is no UK licence on the product e.g. melatonin Unlicensed indication/off label used for a UK licensed medication being used for an unlicensed indication e.g. in children

33 Considerations before using a Special 1. Is the medication still needed at all? 2. Can the patient have a licensed product in a different form e.g. dispersible or liquid? 3. Could you change to a different drug within the same class? 4. Consider using a licensed drug in an unlicensed manner e.g. by dispersing in water or crushing. 1. Not MR / SR as it destroys the release mechanism 2. Not cytotoxic or EC 5. Prescribe the special documenting the reasons for doing so. NB: Patient / carer must be aware that medicine is unlicensed

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services

Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing

More information

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist Policy on Pharmacological Therapies Practice Guidance Note The use of Oral Anti-Cancer Medicines and Oral Methotrexate within - V03 V03 - Issued Issue 1 Dec 15 Planned review December 2018 PPT-PGN 09 Part

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG Introduction All health and social care organisations are accountable for ensuring the safe management of controlled drugs

More information

Coastal West Sussex Interface Prescribing Policy

Coastal West Sussex Interface Prescribing Policy Coastal West Sussex Interface Prescribing Policy Agreement between Commissioners: Coastal West Sussex CCG And Providers: Western Sussex NHS Foundation Trust (WSfT) Sussex Community NHS Trust (SCT) Sussex

More information

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

Crawley CCG LCS Dec 15 Final

Crawley CCG LCS Dec 15 Final Crawley CCG LCS Dec 15 Final Crawley CCG Service Proposal for the inclusion of administration and monitoring of Denosumab 60mg Injection (Prolia )in GP Practices under a Locally Commissioned Service February

More information

Unlicensed Medicines Policy Document

Unlicensed Medicines Policy Document Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale

More information

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning

More information

Authorisation to Administer Medicines

Authorisation to Administer Medicines Authorisation to Administer Medicines Health Guidance Publication date: March 2016 This information sheet is produced for the guidance of Care Inspectorate staff only. The contents should not be regarded

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Serial Prescriptions will be handled by all members of the pharmacy team

Serial Prescriptions will be handled by all members of the pharmacy team Chronic Medication Service (CMS) Standard Operating Procedure- 3 CMS Serial Prescriptions Name of Pharmacy: Address of Pharmacy: Town: Postcode: PPD Contractor Code: Objectives To ensure the efficient

More information

Community Pharmacy Multi-compartment Compliance Aids Audit

Community Pharmacy Multi-compartment Compliance Aids Audit Community Pharmacy Multi-compartment Compliance Aids Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must

More information

Reducing medicines waste in Care Settings.

Reducing medicines waste in Care Settings. Reducing medicines waste in Care Settings. Good practice Guidance Recommendations for care home staff, prescribers and pharmacists working with care homes. This good practice guidance has been developed

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on

More information

How to Report Medication Safety Incidents from a GP Practice on the National Reporting and Learning System (NRLS)

How to Report Medication Safety Incidents from a GP Practice on the National Reporting and Learning System (NRLS) pecialist Pharmacy ervice Medicines Use and afety How to Report Medication afety Incidents from a GP Practice on the National Reporting and Learning ystem (NRL) This document provides a quick explanation

More information

Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre

Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre GUIDELINE VERSION 2 RATIFYING COMMITTEE Drugs and Therapeutics

More information

Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9

Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose

More information

PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE

PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE 1.0 ACTION BY AWMSG: The All Wales Medicines Strategy Group (AWMSG) meeting held on 15 th December 2010 considered and approved the recommendations

More information

Shared Care Agreements for Medicines

Shared Care Agreements for Medicines Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:

More information

Birmingham Children s Hospital

Birmingham Children s Hospital Title Special order medicines in paediatrics Prof Anthony Sinclair Chief Pharmacist Q A Symposium - 2012 Birmingham Children s Hospital We are one of the leading paediatric teaching centres in the country

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

To contact us please

To contact us please Issue 13, June 2015 Newsletter for Care Home staff, General Practitioners and Community Pharmacists The Caring for Care Homes team produced The Medicines Management Checklist in 2010 to provide care homes

More information

Policy for Anticipatory Prescribing and Just in Case Bags

Policy for Anticipatory Prescribing and Just in Case Bags Policy for Anticipatory Prescribing and Just in Case Bags This policy was developed by Milton Keynes End of Life Care Medicine Group and has been adopted by all partner organisations (MK Clinical Commissioning

More information

Procedure For Taking Walk In Patients

Procedure For Taking Walk In Patients Procedure For Taking Walk In Patients 1. Welcome customers and accept prescription(s) from them. All Staff 2. Ensure that the patients personal details are correct and legible To ensure correct details

More information

Medicines Management for Dietitians. Sue Kellie Head of Education and Professional Development The British Dietetic Association

Medicines Management for Dietitians. Sue Kellie Head of Education and Professional Development The British Dietetic Association Medicines Management for Dietitians. Sue Kellie Head of Education and Professional Development The British Dietetic Association Aim of presentation. To give an overview of the current legislation surrounding

More information

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019 PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed

More information

Private Controlled Drugs Prescribing Self-Assessment

Private Controlled Drugs Prescribing Self-Assessment Private Controlled Drugs Prescribing Self-Assessment This self-assessment must be completed prior to issue of: - FP10PCD Private Controlled Drug Prescription forms Please complete ALL relevant parts of

More information

Improving compliance with oral methotrexate guidelines. Action for the NHS

Improving compliance with oral methotrexate guidelines. Action for the NHS Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication

More information

BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING

BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING NON MEDICAL PRESCRIBING ADVISOR IMPLEMENTATION DATE: MAY 2009 REVIEW DATE: MAY 2010 Supplementary Prescribing The working definition of supplementary prescribing

More information

Medicines Management Guidance

Medicines Management Guidance Medicines Management Guidance Status Final Version 1.0 Author Jon Boyd Version date 05/12/2016 Agreed by the following North West London CCGs: Central London West London Hammersmith and Fulham Hounslow

More information

Repeat Prescribing for Practice Staff. Richard Hassett Prescribing Support Technician Inverclyde CHP

Repeat Prescribing for Practice Staff. Richard Hassett Prescribing Support Technician Inverclyde CHP Repeat Prescribing for Practice Staff Richard Hassett Prescribing Support Technician Inverclyde CHP Introduction Aim To highlight and encourage the sharing of good practice in repeat prescribing systems

More information

Medicines Reconciliation: Standard Operating Procedure

Medicines Reconciliation: Standard Operating Procedure Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

PRESCRIBING SUPPORT TECHNICIAN:

PRESCRIBING SUPPORT TECHNICIAN: PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin

More information

NHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House.

NHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. PRESENT: Dr M Ghani (Chair) Medical Director Barnsley CCG (Designate) Dr

More information

PROCEDURE AND GUIDELINES FOR THE ADMINISTRATION OF MEDICATION IN FOOD OR DRINK TO PEOPLE UNABLE TO GIVE CONSENT TO OR WHO REFUSE TREATMENT MM10

PROCEDURE AND GUIDELINES FOR THE ADMINISTRATION OF MEDICATION IN FOOD OR DRINK TO PEOPLE UNABLE TO GIVE CONSENT TO OR WHO REFUSE TREATMENT MM10 MERSEY CARE NHS FOUNDATION TRUST HOW WE MANAGE MEDICINES Medicines Management Services aim to ensure that (i) Service users receive their medicines at times that they need them and in a safe way. (ii)

More information

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire

More information

NHS Fife. Patient Group Direction for Named Community Pharmacists to Supply

NHS Fife. Patient Group Direction for Named Community Pharmacists to Supply Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed

More information

Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services

Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Reference No: Version: 1 Author: Emma Baggaley First Issued On: 1 st March 2018 Latest

More information

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement

Croydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement Shared Care Guideline: Prescribing Agreement Section A: To be completed by the hospital consultant initiating the treatment GP Practice Details: Name: Address: Tel no: Fax no: NHS.net e-mail: Consultant

More information

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie

More information

MEDICINES RECONCILIATION GUIDELINE Document Reference

MEDICINES RECONCILIATION GUIDELINE Document Reference MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012

More information

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse

More information

Pharmacist (Palliative Care) December 2014 Page 1

Pharmacist (Palliative Care) December 2014 Page 1 Job Profile Job Title: Department: Main Location: Hospice Palliative Care Pharmacist 7 NHS (8SRC) Less than full time(0.8) Full time equivalent around 36,300 Head of Clinical Services 1. Main Purpose of

More information

ADMINISTRATION OF MEDICINES POLICY AND PROCEDURES

ADMINISTRATION OF MEDICINES POLICY AND PROCEDURES CITY OF BIRMINGHAM EDUCATION DEPARTMENT BASKERVILLE SCHOOL ADMINISTRATION OF MEDICINES POLICY AND PROCEDURES Date reviewed: May 2017 Next Review: May 2020 BASKERVILLE SCHOOL, FELLOWS LANE, HARBORNE, BIRMINGHAM,

More information

EMERGENCY CARE DISCHARGE SUMMARY

EMERGENCY CARE DISCHARGE SUMMARY EMERGENCY CARE DISCHARGE SUMMARY IMPLEMENTATION GUIDANCE JUNE 2017 Guidance for implementation This section sets out issues identified during the project which relate to implementation of the headings.

More information

Also, you must acknowledge that you understand the following by signing and dating this sheet:

Also, you must acknowledge that you understand the following by signing and dating this sheet: To the parents of You have registered a child for one of our programs and indicated that he or she has a documented life threatening food or insect allergy or other severe allergic reaction that requires

More information

Managing medicines in care homes

Managing medicines in care homes Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience

More information

CCG Policy for Working with the Pharmaceutical Industry

CCG Policy for Working with the Pharmaceutical Industry CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry

More information

Clinical Check of Prescriptions in Ward Areas

Clinical Check of Prescriptions in Ward Areas Pharmacy Department Standard Operating Procedures SOP Title Clinical Check of Prescriptions in Ward Areas Author name and Gareth Price designation: Deputy Director of Pharmacy Clinical Services Pharmacy

More information

Prescribing Quality Review Scheme (PQRS) 2016/17

Prescribing Quality Review Scheme (PQRS) 2016/17 Introduction: The Prescribing Quality Review Scheme (PQRS) has been designed to reflect the four key principles of medicines optimisation: Understanding and improving patient experience. Evidence based

More information

Making medicines safer for children guidance for the use of unlicensed medicines in paediatric patients

Making medicines safer for children guidance for the use of unlicensed medicines in paediatric patients Making medicines safer for children guidance for the use of unlicensed medicines in paediatric patients Rosemont Pharmaceuticals Ltd sponsored the development of this consensus guideline Supplement produced

More information

DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August NHS Doncaster CCG RDaSH FT Doncaster LPC

DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August NHS Doncaster CCG RDaSH FT Doncaster LPC Present: DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August 2015 NHS Doncaster CCG RDaSH FT Doncaster LPC Dr Rumit Shah ( APC Chair) Mr Mark Randerson- Head of Medicines

More information

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers Medicines Management in Care Homes Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers 1. Communication The care home manager, community pharmacist and GP surgery should

More information

CCG authorisation: the role of medicines management

CCG authorisation: the role of medicines management May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets

More information

Out of tariff high cost drug / technology business case template

Out of tariff high cost drug / technology business case template Out of tariff high cost drug / technology business case template Out of tariff high cost drug / technology business case template Please read all the criteria before completing any of the template For

More information

Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian

Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian Lead Author/Coordinator: Jeff Horn / Sarah Howlett Macmillan Haematology CNS/ Pharmacist Reviewer: Gavin Preston Consultant Haematologist

More information

Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, North Derbyshire CCG & Hardwick CCG

Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, North Derbyshire CCG & Hardwick CCG Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, rth Derbyshire CCG & Hardwick CCG CCG Position Statement on the Supply of Multi-Compartment Compliance Aids (MCAs) There

More information

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk

More information

NON MEDICAL PRESCRIBING POLICY

NON MEDICAL PRESCRIBING POLICY NON MEDICAL PRESCRIBING POLICY Document Summary This Policy provides the framework and standards for Non-Medical Prescribing. The application of this policy will ensure that all non-medical prescribers

More information

The Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE

The Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE Chapter 6: Standards of Practice MISCELLANEOUS and DISCHARGE V2.1 Date: October 2015 CHAPTER 6 CONTENTS 6.5. Miscellaneous... 3 6.5.1 Patients Moving Between Healthcare Trusts... 3 6.5.1.1 Transfer of

More information

All Wales Multidisciplinary Medicines Reconciliation Policy

All Wales Multidisciplinary Medicines Reconciliation Policy All Wales Multidisciplinary Medicines Reconciliation Policy June 2017 This document has been prepared by the Quality and Patient Safety Delivery Group of the All Wales Chief Pharmacists Group, with support

More information

Derby Hospitals NHS Foundation Trust. Drug Assessment

Derby Hospitals NHS Foundation Trust. Drug Assessment Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration

More information

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019 Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history

More information

NHS and Private Interface Prescribing Guide

NHS and Private Interface Prescribing Guide NHS and Private Interface Prescribing Guide 1 Background 1.1 The following guide has been developed to assist General Practitioners (GPs) in dealing with requests to prescribe by registered patients following

More information

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS PGD3717 PATIENT GROUP DIRECTION FOR THESUPPLY OF METRONIDAZOLE 400mg TABLETSFOR THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS (TV) by registered nurses and midwives in Integrated Sexual

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION This Patient Group Direction () must only be used by registered pharmacists who have been named and authorised by their organisation to practice under it. The most recent and in date final signed version

More information

Switch protocol: Brands to generic equivalent

Switch protocol: Brands to generic equivalent Switch protocol: Brands to generic equivalent Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for

More information

The Medicines Policy. Chapter 3: Standards of Practice ORDERING WARD STOCK AND NON-STOCKS INPATIENT ITEMS

The Medicines Policy. Chapter 3: Standards of Practice ORDERING WARD STOCK AND NON-STOCKS INPATIENT ITEMS POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

NHS North Somerset Clinical Commissioning Group

NHS North Somerset Clinical Commissioning Group NHS North Somerset Clinical Commissioning Group Medicines Policy - Safe and Secure Handling of Medicines Approved by: Quality and Assurance Group Ratification date: July 2013 Review date: June 2016 Page

More information

Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication

Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Version 2 minor update June 2013 Procedure Number Replaces Policy No. Ratifying Committee N/a PPPF Date Ratified April 2009 Minor

More information

Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy

Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy Andrew Tittershill Content Personal introduction. Defining

More information

Non Medical Prescribing Policy

Non Medical Prescribing Policy Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:

More information

Prescribing Controlled Drugs: Standard Operating Procedure

Prescribing Controlled Drugs: Standard Operating Procedure Clinical Prescribing Controlled Drugs: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

Clinical pharmacists in general practice links with community pharmacy

Clinical pharmacists in general practice links with community pharmacy Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.

More information

Mandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL

Mandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL Mandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL Document Author Written by: Lead Pharmacist/Lead Technician Medicines Use and

More information

Principles of Shared Care Protocols

Principles of Shared Care Protocols Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the

More information

Note: The masculine gender is used throughout this document for the sake of conciseness and is meant to be inclusive of both genders.

Note: The masculine gender is used throughout this document for the sake of conciseness and is meant to be inclusive of both genders. POLICY POLICY ON THE DISTRIBUTION OF MEDICATION IN SCHOOLS (Adopted April 17, 2015) This policy covers all CQSB students that require supervision when taking medication. The policy on distribution of medication

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain

More information

Clinical Commissioning Group

Clinical Commissioning Group Clinical Commissioning Group Title of Meeting: Time: NHS Rotherham Medicines Management Committee Meeting 9.00am 11.00am Date: Wednesday 8 th October 2017 Venue: Reference: Chair: Cedar Room G.02 Oak House

More information

POWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE

POWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE POWYS TEACHING HEALTH BOARD Meeting 04/12/12 Present: PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE Minutes of the meeting held on Thursday, 06 September 2012 at 09.30am in Training Room 1, Bronllys

More information

Expiry Date: January 2009 Template Version: Page 1 of 7

Expiry Date: January 2009 Template Version: Page 1 of 7 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for

More information

ADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL

ADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL Gloucester & Forest Alternative Provision School ADMINISTRATION OF MEDICATION POLICY G&F ALTERNATIVE PROVISION SCHOOL Date:September 2013 PURPOSE The guidance in this policy is to ensure that pupils with

More information

Babylon Healthcare Services

Babylon Healthcare Services Babylon Healthcare Services Limited Babylon Healthcare Services Ltd. Inspection report 60 Sloane Avenue London SW3 3DD Tel: 0207 1000762 Website: www.babylonhealth.com Date of inspection visit: 4 July

More information

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document

More information

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the

More information

Name Job Title Signed Date

Name Job Title Signed Date PGD3517 PATIENT GROUP DIRECTION FOR THE SUPPLY OF AZITHROMYCIN TABS/CAPS 250mg or TABS 500mg OR SUSPENSION 600mg/15mL FOR UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS, UNCOMPLICATED NEISSERIA GONORRHOEA

More information

Consulted With Post/Committee/Group Date Senior Pharmacy Management Team May 2016 Professionally Approved By Jane Giles, Chief Pharmacist June 2016

Consulted With Post/Committee/Group Date Senior Pharmacy Management Team May 2016 Professionally Approved By Jane Giles, Chief Pharmacist June 2016 PMAR (PRESCRIPTION MEDICINE ADMINISTRATION RECORD) ENDORSEMENT BY PHARMACY STAFF CLINICAL GUIDELINE Register no: 10092 Status - Public Developed in response to: Local need Contributes to CQC 12 Consulted

More information

NHS and Private Interface Prescribing Guidance

NHS and Private Interface Prescribing Guidance Version 1.0 Date approved: Date for review: September 2019 Lead Director: Andrew McMylor, Director of Delivery & Development Lead Manager: Nick Beavon, Chief Pharmacist NOTE: This is a CONTROLLED document.

More information

Safe and Secure. Use of Medicines Policy and

Safe and Secure. Use of Medicines Policy and The content of the policies are uncontrolled when printed, check intranet for latest versions Procurement Return & Disposal Safe and Secure Ordering Issue to Patients Administration Use of Medicines Policy

More information

Standard Operating Procedure for When required (PRN) medicines in care homes

Standard Operating Procedure for When required (PRN) medicines in care homes Standard Operating Procedure for When required (PRN) medicines in care homes Introduction All health and social care organisations are responsible for ensuring the safe management of all medicines. This

More information

ORAL ANTI-CANCER THERAPY POLICY

ORAL ANTI-CANCER THERAPY POLICY ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive

More information

NHS PCA (P) (2015) 17 ANNEX B. Specials Frequently Asked Questions for Community Pharmacy. Pre-authorisation:

NHS PCA (P) (2015) 17 ANNEX B. Specials Frequently Asked Questions for Community Pharmacy. Pre-authorisation: ANNEX B Specials Frequently Asked Questions for Community Pharmacy Pre-authorisation: Q: When do I need to seek authorisation? A: You need to seek authorisation for all Specials manufactured medicines

More information

Hospital Pharmacy Transformation Plan

Hospital Pharmacy Transformation Plan Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &

More information

Pharmacy Department, Borders General Hospital

Pharmacy Department, Borders General Hospital 1. JOB IDENTIFICATION Job Title: Responsible to: Department & Base: Clinical Pharmacist BGH Lead Clinical Pharmacist Pharmacy Department, Borders General Hospital Date this JD written/updated: 25.4.14

More information